These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12814453)

  • 1. Evidence of an interaction between nifedipine and nafcillin in humans.
    Lang CC; Jamal SK; Mohamed Z; Mustafa MR; Mustafa AM; Lee TC
    Br J Clin Pharmacol; 2003 Jun; 55(6):588-90. PubMed ID: 12814453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics.
    Harris RZ; Inglis AM; Miller AK; Thompson KA; Finnerty D; Patterson S; Jorkasky DK; Freed MI
    J Clin Pharmacol; 1999 Nov; 39(11):1189-94. PubMed ID: 10579151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of pretreatment periods with diltiazem on nifedipine kinetics.
    Ohashi K; Sudo T; Sakamoto K; Tateishi T; Fujimura A; Kumagai Y; Ebihara A
    J Clin Pharmacol; 1993 Mar; 33(3):222-5. PubMed ID: 8463435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ximelagatran, an oral direct thrombin inhibitor, has a low potential for cytochrome P450-mediated drug-drug interactions.
    Bredberg E; Andersson TB; Frison L; Thuresson A; Johansson S; Eriksson-Lepkowska M; Larsson M; Eriksson UG
    Clin Pharmacokinet; 2003; 42(8):765-77. PubMed ID: 12846597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pioglitazone on the pharmacokinetics of nifedipine and its main metabolite, dehydronifedipine, in rats.
    Choi JS; Choi I; Choi DH
    Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):231-8. PubMed ID: 25549928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation of warfarin-nafcillin interaction during dicloxacillin therapy.
    Taylor AT; Pritchard DC; Goldstein AO; Fletcher JL
    J Fam Pract; 1994 Aug; 39(2):182-5. PubMed ID: 8057070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide.
    Hatorp V; Hansen KT; Thomsen MS
    J Clin Pharmacol; 2003 Jun; 43(6):649-60. PubMed ID: 12817528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits.
    Shirtliff ME; Calhoun JH; Mader JT
    J Antimicrob Chemother; 2001 Aug; 48(2):253-8. PubMed ID: 11481297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose dependent effect of diltiazem on the pharmacokinetics of nifedipine.
    Tateishi T; Ohashi K; Sudo T; Sakamoto K; Toyosaki N; Hosoda S; Toyo-oka T; Kumagai Y; Sugimoto K; Fujimura A
    J Clin Pharmacol; 1989 Nov; 29(11):994-7. PubMed ID: 2600195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and cerebrospinal fluid concentration of nafcillin in pediatric patients undergoing cerebrospinal fluid shunt placement.
    Nahata MC; Fan-Havard P; Kosnik EJ; Bartkowski MH; Barson WJ
    Chemotherapy; 1990; 36(2):98-102. PubMed ID: 2311446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of co-trimoxazole on the pharmacokinetics and pharmacodynamics of nifedipine.
    Edwards C; Monkman S; Cholerton S; Rawlins MD; Idle JR; Ferner RE
    Br J Clin Pharmacol; 1990 Dec; 30(6):889-91. PubMed ID: 2288835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers.
    Ridtitid W; Wongnawa M; Mahatthanatrakul W; Punyo J; Sunbhanich M
    Clin Pharmacol Ther; 2002 Nov; 72(5):505-13. PubMed ID: 12426514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of drug-drug interaction between cerivastatin and nifedipine.
    Sachse R; Brendel E; Mück W; Rohde G; Ochmann K; Horstmann R; Kuhlmann J
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):409-13. PubMed ID: 9726692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of probenecid on nafcillin disposition.
    Waller ES; Sharanevych MA; Yakatan GJ
    J Clin Pharmacol; 1982 Oct; 22(10):482-9. PubMed ID: 7174857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
    Deng S; Chen XP; Cao D; Yin T; Dai ZY; Luo J; Tang L; Li YJ
    Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the pharmacokinetic and pharmacodynamic interaction between quinidine and nifedipine.
    Bowles SK; Reeves RA; Cardozo L; Edwards DJ
    J Clin Pharmacol; 1993 Aug; 33(8):727-31. PubMed ID: 8408733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclosporine on drug transport and pharmacokinetics of nifedipine.
    Dorababu M; Nishimura A; Prabha T; Naruhashi K; Sugioka N; Takada K; Shibata N
    Biomed Pharmacother; 2009 Nov; 63(9):697-702. PubMed ID: 19819100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pantoprazole does not interact with nifedipine in man under steady-state conditions.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Kunz K; Wurst W
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):51-5. PubMed ID: 8929746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice.
    Rashid J; McKinstry C; Renwick AG; Dirnhuber M; Waller DG; George CF
    Br J Clin Pharmacol; 1993 Nov; 36(5):460-3. PubMed ID: 12959295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.